All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
GERN / Geron Corporation
|
|
|
|
|
|
|
|
ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
LPTX / Leap Therapeutics, Inc.
|
|
|
|
|
|
|
|
OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
DSGN / Design Therapeutics, Inc.
|
|
|
|
|
|
|
|
ATXS / Astria Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
KYTX / Kyverna Therapeutics, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc. Call
|
|
|
|
|
|
|
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
ATYR / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CGEM / Cullinan Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
IOBT / IO Biotech, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
ENGN / enGene Holdings Inc.
|
|
|
|
|
|
|
|
APLT / Applied Therapeutics, Inc.
|
|
|
|
|
|
|
|
CGON / CG Oncology, Inc.
|
|
|
|
|
|
|
|
NMRA / Neumora Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SLRN / Acelyrin, Inc.
|
|
|
|
|
|
|
|
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
ZNTL / Zentalis Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
ICVX / Icosavax, Inc.
|
|
|
|
|
|
|
|
RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
RYZB / RayzeBio, Inc.
|
|
|
|
|
|
|
|
RPTX / Repare Therapeutics Inc.
|
|
|
|
|
|
|
|
MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
AMAM / Ambrx Biopharma Inc.
|
|
|
|
|
|
|
|
INBX / Inhibrx Biosciences, Inc. Call
|
|
|
|
|
|
|
|
DCTH / Delcath Systems, Inc.
|
|
|
|
|
|
|
|
MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
MOR / MorphoSys AG - Depositary Receipt (Common Stock) Call
|
|
|
|
|
|
|
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
CYBN / Cybin Inc.
|
|
|
|
|
|
|
|
LRMR / Larimar Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
LCTX / Lineage Cell Therapeutics, Inc.
|
|
|
|
|
|
|
|
ANNX / Annexon, Inc.
|
|
|
|
|
|
|
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) Call
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
UNCY / Unicycive Therapeutics, Inc.
|
|
|
|
|
|
|
|
ANNX / Annexon, Inc. Call
|
|
|
|
|
|
|
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|